Skip to main content
Top
Published in: BMC Public Health 1/2017

Open Access 01-12-2017 | Study protocol

Study protocol of the German Study on Tobacco Use (DEBRA): a national household survey of smoking behaviour and cessation

Authors: Sabrina Kastaun, Jamie Brown, Leonie S. Brose, Elena Ratschen, Tobias Raupach, Dennis Nowak, Constanze Cholmakow-Bodechtel, Lion Shahab, Robert West, Daniel Kotz

Published in: BMC Public Health | Issue 1/2017

Login to get access

Abstract

Background

The prevalence of tobacco smoking in Germany is high (~27%). Monitoring of national patterns of smoking behaviour and data on the “real-world” effectiveness of cessation methods are needed to inform policies and develop campaigns aimed at reducing tobacco-related harm. In England, the Smoking Toolkit Study (STS) has been tracking such indicators since 2006, resulting in the adaptation of tobacco control policies. However, findings cannot be directly transferred into the German health policy context. The German Study on Tobacco Use (DEBRA: “Deutsche Befragung zum Rauchverhalten”) aims to provide such nationally representative data.

Methods/Design

In June 2016, the study started collecting data from computer-assisted, face-to-face household interviews in people aged 14 years and older. Over a period of 3 years, a total of ~36,000 respondents will complete the survey with a new sample of ~2000 respondents every 2 months (=18 waves). This sample will report data on demographics and the use of tobacco and electronic (e-)cigarettes. Per wave, about 500–600 people are expected to be current or recent ex-smokers (<12 months since quitting). This sample will answer detailed questions about smoking behaviour, quit attempts, exposure to health professionals’ advice on quitting, and use of cessation aids. Six-month follow-up data will be collected by telephone.

Discussion

The DEBRA study will be an important source of data for tobacco control policies, health strategies, and future research. The methodology is closely aligned to the STS, which will allow comparisons with data from England, a country with one of the lowest smoking prevalence rates in Europe (18%).

Trial registration

This study has been registered at the German Clinical Trials Register (DRKS00011322) on 25th November 2016.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mons U. Tobacco-attributable mortality in Germany and in the German Federal States – calculations with data from a microcensus and mortality statistics.[Article in German] Gesundheitswesen. 2011;73:238-246. Mons U. Tobacco-attributable mortality in Germany and in the German Federal States – calculations with data from a microcensus and mortality statistics.[Article in German] Gesundheitswesen. 2011;73:238-246.
4.
go back to reference Lampert T, von der Lippe E, Muters S. Prevalence of smoking in the adult population of Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). [Article in German] Bundesgesundhbl Gesundheitsforsch Gesundheitsschutz. 2013;56:802-808. Lampert T, von der Lippe E, Muters S. Prevalence of smoking in the adult population of Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). [Article in German] Bundesgesundhbl Gesundheitsforsch Gesundheitsschutz. 2013;56:802-808.
5.
go back to reference Lampert T. Social determinants of tobacco consumption among adults in Germany. [Article in German].Bundesgesundhbl Gesundheitsforsch Gesundheitsschutz. 2010;53:108-116. Lampert T. Social determinants of tobacco consumption among adults in Germany. [Article in German].Bundesgesundhbl Gesundheitsforsch Gesundheitsschutz. 2010;53:108-116.
6.
go back to reference Mackenbach JP, Stirbu I, Roskam A-JR, Schaap MM, Menvielle G, Leinsalu M, et al. Socioeconomic Inequalities in Health in 22 European Countries. New Engl J Med. 2008;358:2468–81.CrossRefPubMed Mackenbach JP, Stirbu I, Roskam A-JR, Schaap MM, Menvielle G, Leinsalu M, et al. Socioeconomic Inequalities in Health in 22 European Countries. New Engl J Med. 2008;358:2468–81.CrossRefPubMed
8.
go back to reference Lampert T, Kuntz B. Tobacco and alcohol consumption among 11- to 17-year-old adolescents: results of the KiGGS study: first follow-up (KiGGS Wave 1) [Article in German]. Bundesgesundhbl Gesundheitsforsch Gesundheitsschutz. 2014;57:830-839. Lampert T, Kuntz B. Tobacco and alcohol consumption among 11- to 17-year-old adolescents: results of the KiGGS study: first follow-up (KiGGS Wave 1) [Article in German]. Bundesgesundhbl Gesundheitsforsch Gesundheitsschutz. 2014;57:830-839.
10.
go back to reference Piontek D, Kraus L,Gomes de Matos E, Atzendorf J. Der Epidemiologische Suchtsurvey 2015: Studiendesign und Methodik [Article in German]. Sucht. 2016;62:259–269. Piontek D, Kraus L,Gomes de Matos E, Atzendorf J. Der Epidemiologische Suchtsurvey 2015: Studiendesign und Methodik [Article in German]. Sucht. 2016;62:259–269.
11.
go back to reference Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005;18(2):CD001292. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005;18(2):CD001292.
12.
go back to reference Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;31(5):CD000165. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;31(5):CD000165.
13.
go back to reference Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005;18(2):CD001007. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005;18(2):CD001007.
14.
go back to reference Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2012;18(4):CD006103. Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2012;18(4):CD006103.
15.
go back to reference Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:CD008286.PubMed Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:CD008286.PubMed
16.
go back to reference Fidler JA, Shahab L, West O, Jarvis MJ, McEwen A, Stapleton JA, et al. 'The smoking toolkit study': a national study of smoking and smoking cessation in England. BMC Public Health. 2011;11:479.CrossRefPubMedPubMedCentral Fidler JA, Shahab L, West O, Jarvis MJ, McEwen A, Stapleton JA, et al. 'The smoking toolkit study': a national study of smoking and smoking cessation in England. BMC Public Health. 2011;11:479.CrossRefPubMedPubMedCentral
17.
go back to reference Kotz D, Brown J, West R. 'Real-world' effectiveness of smoking cessation treatments: a population study. Addiction. 2014;109:491–9.CrossRefPubMed Kotz D, Brown J, West R. 'Real-world' effectiveness of smoking cessation treatments: a population study. Addiction. 2014;109:491–9.CrossRefPubMed
19.
go back to reference Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Spyrou A, Vouthis V. Impact of flavour variability on electronic cigarette use experience: an internet survey. Int J Env Res Pub He. 2013;10:7272–82.CrossRef Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Spyrou A, Vouthis V. Impact of flavour variability on electronic cigarette use experience: an internet survey. Int J Env Res Pub He. 2013;10:7272–82.CrossRef
20.
go back to reference Brown J. A gateway to more productive research on e-cigarettes? Commentary on a comprehensive framework for evaluating public health impact. Addiction. 2017;112:21–2.CrossRefPubMed Brown J. A gateway to more productive research on e-cigarettes? Commentary on a comprehensive framework for evaluating public health impact. Addiction. 2017;112:21–2.CrossRefPubMed
21.
go back to reference Kish L. A Procedure for Objective Respondent Selection within the Household. JASA. 1949;44:380–7.CrossRef Kish L. A Procedure for Objective Respondent Selection within the Household. JASA. 1949;44:380–7.CrossRef
22.
go back to reference Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8:94–104.CrossRefPubMed Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8:94–104.CrossRefPubMed
23.
go back to reference Kotz D, Brown J, West R. Prospective cohort study of the effectiveness of smoking cessation treatments used in the “real world”. Mayo Clin Proc. 2014;89:1360–7.CrossRefPubMedPubMedCentral Kotz D, Brown J, West R. Prospective cohort study of the effectiveness of smoking cessation treatments used in the “real world”. Mayo Clin Proc. 2014;89:1360–7.CrossRefPubMedPubMedCentral
25.
go back to reference Borland R, Partos TR, Cummings KM. Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res. 2012;14:1483–7.CrossRefPubMedPubMedCentral Borland R, Partos TR, Cummings KM. Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res. 2012;14:1483–7.CrossRefPubMedPubMedCentral
26.
go back to reference Kotz D, West R. Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob Control. 2009;18:43–6.CrossRefPubMed Kotz D, West R. Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob Control. 2009;18:43–6.CrossRefPubMed
27.
go back to reference Kotz D, Brown J, West R. Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking. Drug Alcohol Depend. 2013;128:15–9.CrossRefPubMed Kotz D, Brown J, West R. Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking. Drug Alcohol Depend. 2013;128:15–9.CrossRefPubMed
28.
go back to reference Ussher M, Kakar G, Hajek P, West R. Dependence and motivation to stop smoking as predictors of success of a quit attempt among smokers seeking help to quit. Addictive Behaviors. 2016;53:175–80.CrossRefPubMed Ussher M, Kakar G, Hajek P, West R. Dependence and motivation to stop smoking as predictors of success of a quit attempt among smokers seeking help to quit. Addictive Behaviors. 2016;53:175–80.CrossRefPubMed
29.
go back to reference Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res. 2012;14:75–8.CrossRefPubMed Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res. 2012;14:75–8.CrossRefPubMed
30.
go back to reference Fidler JA, Shahab L, West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerstrom Test for Nicotine Dependence and its components. Addiction. 2011;106:631–8.CrossRefPubMed Fidler JA, Shahab L, West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerstrom Test for Nicotine Dependence and its components. Addiction. 2011;106:631–8.CrossRefPubMed
32.
go back to reference Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382:1629–37.CrossRefPubMed Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382:1629–37.CrossRefPubMed
33.
go back to reference Kröger CB,Gomes de Matos E, Piontek D, Wenig JR Quitting attempts and utilisation of smoking cessation aids among smokers in Germany: results from the 2012 Epidemiological Survey of Substance Abuse.[Article in German] Gesundheitswesen. 2016;78:752-758. Kröger CB,Gomes de Matos E, Piontek D, Wenig JR Quitting attempts and utilisation of smoking cessation aids among smokers in Germany: results from the 2012 Epidemiological Survey of Substance Abuse.[Article in German] Gesundheitswesen. 2016;78:752-758.
34.
go back to reference Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29–38.CrossRefPubMed Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29–38.CrossRefPubMed
35.
go back to reference Kotz D, Fidler J, West R. Factors associated with the use of aids to cessation in English smokers. Addiction. 2009;104:1403–10.CrossRefPubMed Kotz D, Fidler J, West R. Factors associated with the use of aids to cessation in English smokers. Addiction. 2009;104:1403–10.CrossRefPubMed
36.
go back to reference Stead L, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008;16(2):CD000165. Stead L, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008;16(2):CD000165.
37.
go back to reference West R, Raw M, McNeill A, Stead L, Aveyard P, Bitton J, et al. Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction. 2015;110:1388–403.CrossRefPubMedPubMedCentral West R, Raw M, McNeill A, Stead L, Aveyard P, Bitton J, et al. Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction. 2015;110:1388–403.CrossRefPubMedPubMedCentral
38.
go back to reference Twardella D, Brenner H. Lack of training as a central barrier to the promotion of smoking cessation: a survey among general practitioners in Germany. Eur J Public Health. 2005;15:140–5.CrossRefPubMed Twardella D, Brenner H. Lack of training as a central barrier to the promotion of smoking cessation: a survey among general practitioners in Germany. Eur J Public Health. 2005;15:140–5.CrossRefPubMed
39.
go back to reference Kotz D, Brown J, West R. Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the "real world". BMC Public Health. 2014;14:1163.CrossRefPubMedPubMedCentral Kotz D, Brown J, West R. Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the "real world". BMC Public Health. 2014;14:1163.CrossRefPubMedPubMedCentral
40.
go back to reference Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction. 2014;109:1531–40.CrossRefPubMedPubMedCentral Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction. 2014;109:1531–40.CrossRefPubMedPubMedCentral
Metadata
Title
Study protocol of the German Study on Tobacco Use (DEBRA): a national household survey of smoking behaviour and cessation
Authors
Sabrina Kastaun
Jamie Brown
Leonie S. Brose
Elena Ratschen
Tobias Raupach
Dennis Nowak
Constanze Cholmakow-Bodechtel
Lion Shahab
Robert West
Daniel Kotz
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2017
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-017-4328-2

Other articles of this Issue 1/2017

BMC Public Health 1/2017 Go to the issue